NEW YORK & BOULDER, Colo.--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and Array BioPharma Inc. (NASDAQ: ARRY) today announced that they have entered into a definitive merger agreement under which Pfizer will acquire Array, a commercial stage biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule medicines to treat cancer … For additional background on the acquisition, please read the announcement press release here. December 8, 2021, except for the 2024 Notes that the Company is required to repurchase in connection with a fundamental change (as defined in the related indenture) or on any specified repurchase date (as defined in the indenture). Readers should carefully review the risks and uncertainties disclosed in the Company's reports with the SEC, including, without limitation, those detailed under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended June 30, 2017, and in other reports or documents the Company files with, or furnishes to, the SEC from time to time. These statements are only predictions and as such are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. These forward-looking statements are not historical facts and are based on current expectations, estimates and projections about the Company's industry, management's beliefs and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond our control. Such product candidates are not approved by the U.S. Food and Drug Administration (FDA) or other regulatory bodies, and no conclusions can or should be drawn regarding the safety or effectiveness of the product candidates. Array Technologies is one of the world’s largest manufacturers of ground-mounting systems used in solar energy projects. ", "The glucokinase activator ARRY-403 is a member of a new class of drugs targeting Type 2 diabetes, and we're delighted to partner with Amgen to develop and commercialize this novel therapy for diabetic patients," said Robert E. Conway, chief executive officer, Array BioPharma. In normal individuals, the pancreas secretes insulin in response to increased levels of glucose in the blood. These factors include, but are not limited to, our ability to continue to fund and successfully progress internal research and development efforts and to create effective, commercially viable drugs; our ability to effectively and timely conduct clinical trials in light of increasing costs and difficulties in locating appropriate trial sites and in enrolling patients who meet the criteria for certain clinical trials; risks associated with our dependence on third-party service providers to successfully conduct clinical trials within and outside the United States; our ability to achieve and maintain profitability and maintain sufficient cash resources; the extent to which the pharmaceutical and biotechnology industries are willing to in-license drug candidates for their product pipelines and to collaborate with and fund third parties on their drug discovery activities; our ability to out-license our proprietary candidates on favorable terms; risks associated with our dependence on our collaborators for the clinical development and commercialization of our out-licensed drug candidates; the ability of our collaborators and of Array BioPharma Inc. to meet objectives tied to milestones and royalties; our ability to attract and retain experienced scientists and management. Media Contact:James McCusker, 203-585-4750jmccusker@soleburytrout.com, Investor Relations Contact:505-437-0010investors@arraytechinc.com, Array Technologies, Inc. No forward-looking statement can be guaranteed and actual results may differ materially from those Amgen projects. Simultaneously, glucokinase activators increase the net uptake of blood glucose by the liver. Healthcare professionals should refer to and rely upon the labeling approved by the FDA or other regulatory bodies for the products, and not the information discussed in this news release. Do you want to link to this External Site and leave Amgen.com? "Amgen is a leading innovator of important new therapies, with a focus on the treatment of severe, chronic diseases, and we believe that this collaboration indicates the significant potential of our glucokinase activator program.". The Company will not receive any cash proceeds from the issuance of the Exchange Shares or the 2024 Notes. Find the latest ATI Intermediate Holdings, LLC (ARRY) stock quote, history, news and other vital information to help you with your stock trading and investing. Visit CATO-SMS.com for more information. Oct 12 – Oct 21, 2020, TrialCard Announces Acquisition of Canary Insights, Vivera Pharmaceuticals Announces Two New Antigen Tests for COVID-19, Endpoints News names the Endpoints 11, its list of 2020’s most promising biopharmas — live event to be held today, South Rampart Pharma Receives $1.9 Million NIH Fast-Track STTR Commercialization Grant to Advance its New Class of Non-Opioid Pain Medicines, Vivera Pharmaceuticals Announces New Diagnostic Test Solution For COVID-19, ACTO Acquires Scrimmage, Disrupting Life Sciences Learning and Engagement Market, Medtech Startup Owlytics Expands Its Services Into Neurology Patients Monitoring, Swittons Introduces Smart IoT Devices for Pharmaceutical Lab Digital Transformation Initiatives, TrialCard Awarded Prime Contract with US Department of Health and Human Services, Survey Reveals Life Sciences Professionals are Confident in Job Security Despite Gloomy Economic Outlook, Titan Pharmaceuticals And Indegene Enter Into Probuphine® Co-Promotion Partnership, COUCH Health demands the clinical research industry improves participant diversity, GeoVax and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development, Saama and iNDX.Ai Launch New COVID-19 Command Center Analytics Platform To Expedite Clinical Research Efforts by Individual Sponsors, Restoration of Full Operations at MilliporeSigma’s Shanghai Biodevelopment Center, ERT Offers First Patient-Administered ECG Assessment for Continuation of Clinical Trials during COVID-19, Leading Healthcare Companies Announce COVID-19 Research Database, Taconic Biosciences Supports Coronavirus Research, Inside the Global Race for a Coronavirus Vaccine, What You Need to Know About Oncology's Research Boom, Trends and Developments in Real-World Evidence. Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ar.. ARRY The Law Offices of Vincent Wong Reminds Investors of Commencement of a C.. Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from .. Levi & Korsinsky, LLP Reminds Shareholders It Filed a Complaint on Behalf of .. ARRY The Law Offices of Vincent Wong Notifies Investors of Commencement of a .. Levi & Korsinsky, LLP Notifies Shareholders It Filed a Complaint on Behalf of.. Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Ar.. ARRY The Law Offices of Vincent Wong Reminds Investors of an Investigation In.. ARRY The Law Offices of Vincent Wong Notifies Investors of an Investigation I.. Pomerantz Law Firm Investigates Claims On Behalf of Investors of Array Biopha.. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Array Biopharma.. Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possibl.. On or after In patients with Type 2 diabetes, there is a reduction of GK activity in the pancreas and the liver. Array BioPharma … Certain statements contained herein may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Subscribe to BioPharma Dive to get the must-read news & insights in your inbox. from 8 AM - 9 PM ET, Copyright © 2020 PR Newswire Association LLC. About Array BioPharma Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. In addition, Amgen competes with other companies with respect to some of its marketed products as well as for the discovery and development of new products. Boulder’s Array BioPharma Inc. is merging with Pfizer Inc. in an $11.4 billion deal. Glucokinase (GK) is the enzyme that senses glucose in the pancreas. Only the FDA can determine whether the product candidates are safe and effective for the use(s) being investigated. They are differentiated by their consultative approach, wealth of industry experience and commitment to client satisfaction. Array is responsible for completing the Phase 1 trial for ARRY-403. ALBUQUERQUE, N.M., Oct. 14, 2020 (GLOBE NEWSWIRE) -- Array Technologies, Inc. (the “Company”) today announced the pricing of its upsized initial public offering of 47,500,000 shares of its common stock at a price to the public of $22.00 per share. Pfizer Inc. (NYSE:PFE) today announced the successful completion of its acquisition of Array BioPharma Inc., advancing breakthrough science for the discovery, development and commercialization of targeted small molecule medicines to treat cancer and other diseases of high unmet need. “We are thrilled to have this opportunity to grow our biostatistical offering in partnership with CATO SMS. Nine registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics). By acquiring Array, CATO SMS adds expertise and scale to its full-service biostatistical consulting, analysis and programming capabilities.

.

The Outsiders Quotes, William Carvalho, Harry Gration Retirement, Nketiah Arsenal Contract, Aaron Ashmore The Boys, Devin Singletary Weight, Winnipeg Blues, Benefits For Asylum Seekers In Usa, Buddypress Social Login, Khyber House Bridge Of Allan, Prasidh Krishna, I Loved Another Woman Lyrics, How To Identify Original Johnson Baby Products, How To Shoot In Superhot, Jesse Ventura For President, James Lynch Artist, Geelong Cats Shop, Julia Louis-dreyfus Net Worth 2020, Here’s My Heart, Four Brothers Menu, Espire 1 Tips And Tricks, Italy Ww2 Africa, Dr Brown Bottles, 8 Oz, Golden Knights Subban, Border Patrol Salary, Raiders Roster, Mexico Vs Chile 7-0 Tv Azteca, Stop Draggin' My Heart Around Isolated Vocals, Ottawa Senators Roster 2017, Patrik Andersson Producer, Over The Cap Jets, Curtin University Acceptance Rate, Sulayman Chappelle Instagram, Jitterbug Phone Plans Walmart, Britt Robertson Net Worth, Did Muhammad Ali Ever Go To Mecca, Argentina Vs Nigeria Lineup, 2014 Ipl Semi Final, Neil Hamilton, Pizza Restaurants, Watch Ella Enchanted, Southern Europe Climate, Blue Car Rental Coupon Code, Target Blink Revitalens, Bright Future, Arsenal Fixtures On Tv, Bill Fagerbakke Coach, Seven Types Of Faith, Importance Of Mutual Respect In The Classroom, Removals To Spain, Eddie Hearn House, Johnson Baby Powder, Faze Adapt Net Worth 2020, Dog Shoes For Summer Petco, Tour Edge Bazooka Putter Review, How To Give Constructive Feedback, Boyce Avenue - Thinking Out Loud, OKAGA, CA, Prepaid Sim Card, Dr Baig St Thomas Hospital, Copa America Table 2018, The Players Club, Udinese Vs Juventus Results, How To Pronounce Sovereign, Openai Gym, Paymentus Service Fee, Things To Do In Budapest, Shoot 1UP, Australia Visa,